Microfluidic device for forming monodisperse lipoplexes
View Patent ↗A method for forming monodisperse lipoplex assemblies includes providing a microfluidic device having a main microfluidic channel coupled to first and second reactant inlet channels. The first inlet channel is used to deliver a cationic lipid to the main channel while the second channel is used to deliver a nucleic acid. A droplet generation zone is provided in the main channel at the intersection of first and second carrier channels that contain a hydrophobic fluid. The cationic lipid, nucleic acid, and the hydrophobic fluid are then pumped through the device. In the droplet generation zone, shear force from the hydrophobic fluid pinches off droplets. The cationic lipid and nucleic acid are mixed in the generated droplets as the droplets move within a mixing region. A plurality of splitting channels may be coupled to the outlet of the device to produce smaller, monodisperse droplets having picoliter volumes.
1. A method of forming monodisperse lipoplex assemblies, said lipoplex assemblies comprising a complex formed between a cationic lipid and a nucleic acid, the method comprising:
providing a microfluidic device having a main channel including a droplet generation zone, the droplet generation zone comprising an intersection between the main channel and a first and a second carrier channels configured to receive a hydrophobic fluid, the microfluidic device further comprising a first and a second inlet channels coupled to the main channel at a region upstream from the droplet generation zone;
providing a first reactant in fluid communication with the first inlet channel, the first reactant comprising a cationic lipid;
providing a second reactant in fluid communication with the second inlet channel, the second reactant comprising a nucleic acid;
providing a hydrophobic fluid in fluid communication with the first and second carrier channels;
flowing the first and second reactants and the hydrophobic fluid into the droplet generation zone to form aqueous droplets;
mixing the aqueous droplets containing the cationic lipid and the nucleic acid by passing the same in a single direction through a mixing region downstream of the droplet generation zone, the mixing region comprising a sawtooth-shaped channel configured to induce convective flow inside the droplets, wherein said mixing generates a plurality of aqueous droplets containing a plurality of monodisperse lipoplex assemblies; and
splitting the generated aqueous droplets into a plurality of smaller sized aqueous droplets containing plurality of monodisperse lipoplex assemblies having substantially the same number of cationic lipid and nucleic acid molecules in a single droplet that is generally electrically neutral.
2. The method of claim 1 , wherein the nucleic acid comprises DNA.
3. The method of claim 1 , wherein the hydrophobic fluid comprises oil.
4. The method of claim 1 , wherein the splitting is accomplished using a plurality of branch channels.
5. The method of claim 4 , further comprising delivering the smaller sized aqueous droplets containing a plurality of monodisperse lipoplex assemblies into a common incubation chamber coupled to each branch channel.
6. The method of claim 4 , further comprising splitting the already-split aqueous droplets containing a plurality of monodisperse lipoplex assemblies into a plurality of yet smaller sized aqueous droplets containing a plurality of monodisperse lipoplex assemblies.
7. The method of claim 6 , wherein the yet smaller sized aqueous droplets containing a plurality of monodisperse lipoplex assemblies have volumes less than about 50 picoliters.
8. The method of claim 6 , wherein the splitting is accomplished using a plurality of secondary branch channels.
9. The method of claim 6 , further comprising extracting the plurality of monodisperse lipoplex assemblies of uniform size of less than 500 nm from the yet smaller sized aqueous droplets.
10. The method of claim 1 , wherein the cationic lipid comprises N-[1-(2,3-dioleyloxy) propyl]-N,N,N-trimetylammonium chloride/1,2-Dioleoyl-sn-glycero-phosphatidylethanolamin (DOTMA/DOPE) in a 1:1 (weight/weight) ratio.